Andere talen Kyowa Corporation

Aandelen

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
886 ^JPY	0,00%		+3,87%	+9,79%

07/05	Winst Kyowa Kirin 15% hoger in Q1	MT
02/05	Aandelen BridgeBio Pharma dalen na financiële resultaten Q1	MT

Kyowa Kirin's Profit Up 15% in Q1	07/05
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06/05
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03/04
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18/03
US approves first gene therapy for children with rare genetic disease	18/03
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	05/03
China Deflation, Bank of Japan Roil Asian Stock Markets	08/02
MÄRKTE ASIEN/Tokio sehr fest auf 34-Jahreshoch - Softbank mit Kurssprung	08/02
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	08/02
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	08/02
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan	07/02
Kyowa Kirin's Profit Up 52% in Fiscal 2023	07/02
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	26/01
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics	26/01
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24/01
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23/01

Geen resultaten voor deze zoekopdracht